BioTelemetry Inc. (BEAT) had a rough trading day for Thursday January 03 as shares tumbled 6.72%, or a loss of $-3.99 per share, to close at $55.35. After opening the day at $58.83, shares of BioTelemetry Inc. traded as high as $59.60 and as low as $55.00. Volume was 602,723 shares over 7,957 trades, against an average daily volume of n/a shares and a total float of 33.3 million.
As a result of the decline, BioTelemetry Inc. now has a market cap of $1.84 billion.
The stock has a P/E Ratio of 147.3.
BioTelemetry Inc provides monitoring services and digital population health management for healthcare providers, medical device manufacturing, and centralized core laboratory services for clinical research. It operates under healthcare, technology, and research segments. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials and the Technology segment, focuses on the development, manufacturing, testing, and marketing of cardiovascular and blood glucose monitoring devices to medical companies, clinics and hospitals.
BioTelemetry Inc. is based out of Malvern, PA and has some 1,600 employees. Its CEO is Joseph H. Capper.